DHT & Genetic Pattern Hair Loss: Causes, Symptoms & Solutions

Dihydrotestosterone (DHT) and inherited follicle sensitivity are central drivers of androgenetic alopecia, the common form of genetic pattern hair loss that affects both men and women.

DHT does not simply make everyone’s hair fall out. Instead, genetically susceptible scalp follicles respond differently to androgen activity. Over repeated hair cycles, these follicles can gradually miniaturise and produce finer, shorter and less visible hairs.

In men, this process commonly causes temple recession, a changing frontal hairline and crown thinning. In women, androgenetic alopecia more often appears as a widening central part and reduced density across the top of the scalp.

Pattern hair loss is usually progressive. However, early diagnosis and consistent treatment can help slow further miniaturisation, preserve existing hair and improve density in some people.

Importantly, DHT does not cause every form of hair loss. Sudden shedding, patchy loss, scalp inflammation, nutritional deficiency, thyroid disease, medication effects and scarring alopecia require different approaches.

Medical note: This guide is educational and does not provide a personal diagnosis or prescription. Prescription hair-loss medicines require assessment by an appropriately qualified healthcare professional.

What Is Androgenetic Alopecia?

Androgenetic alopecia is the medical term for genetic pattern hair loss.

It is a common, progressive and non-scarring form of hair loss that can affect both men and women.

The name reflects two important parts of the condition:

• Androgen: Androgen signalling, particularly involving DHT, contributes to follicular miniaturisation in susceptible scalp areas.
• Genetic: Inherited factors influence which follicles are susceptible and how strongly they respond.

Over repeated growth cycles, affected follicles gradually produce thinner and shorter hairs. This process is called follicular miniaturisation.

For the broader condition overview, read our complete androgenetic alopecia guide.

What Is DHT?

DHT stands for dihydrotestosterone. It is an androgen produced when the enzyme 5-alpha-reductase converts testosterone into DHT.

DHT has normal biological functions in the human body. It should not be treated as a harmful hormone simply because it is involved in pattern hair loss.

The problem occurs when scalp follicles are genetically susceptible to androgen signalling.

In those follicles, DHT can contribute to progressive changes in the hair-growth cycle and follicle size.

For a deeper explanation, read what DHT is and how it affects hair loss.

How DHT Affects Genetically Sensitive Hair Follicles

DHT interacts with androgen receptors within susceptible follicles.

Over repeated hair cycles, androgen signalling can contribute to a shorter active growth phase and progressive follicular miniaturisation.

As this process continues, affected hairs may become:

• Finer in diameter.
• Shorter.
• Less pigmented.
• Less visible above the scalp.
• Less effective at providing scalp coverage.

Eventually, terminal hairs can become very fine, vellus-like hairs.

That is why genetic pattern hair loss can appear to progress even though the follicles do not suddenly disappear.

DHT Does Not Affect Every Scalp Follicle Equally

Androgen sensitivity varies by scalp location.

In many men with androgenetic alopecia, follicles across the frontal scalp, temples and crown are more susceptible, while follicles at the sides and back are relatively resistant.

This difference is one reason appropriately selected donor hairs from the occipital and lateral scalp can be used during hair transplantation.

However, donor-area stability must still be assessed because not every patient has equally resistant donor hair.

Does High DHT Automatically Mean Hair Loss?

No.

A person can have normal circulating androgen levels and still develop androgenetic alopecia.

Conversely, a high androgen level does not automatically mean that every scalp follicle will miniaturise.

The interaction between genetics, androgen signalling and local follicular sensitivity is more important than a single blood DHT measurement.

DHT Hair Loss Is Non-Scarring

Androgenetic alopecia is classified as a non-scarring alopecia.

Follicular openings normally remain visible, particularly earlier in the condition.

This differs from scarring alopecia, where inflammatory processes can permanently damage follicles and replace them with scar tissue.

Symptoms such as significant:

• Scalp pain.
• Burning.
• Pustules.
• Heavy crusting.
• Marked redness.
• Loss of follicular openings.
• Smooth or shiny scar-like areas.

are not typical of uncomplicated androgenetic alopecia and should be professionally evaluated.

Why Genetics Matter in Pattern Hair Loss

Androgenetic alopecia is a complex genetic condition.

It is not inherited only from the mother’s side of the family.

Genes inherited from both parents can influence susceptibility, and multiple genetic variants appear to contribute.

Inherited factors may influence:

• Whether pattern hair loss develops.
• Age of onset.
• Follicle sensitivity.
• Pattern of thinning.
• Rate of progression.
• Severity.

A strong family history increases the likelihood of genetic pattern hair loss. However, it cannot predict exactly when thinning will begin or how advanced it will become.

Symptoms of DHT and Genetic Pattern Hair Loss

Androgenetic alopecia generally progresses slowly over months or years.

Common signs include:

• Gradual rather than sudden thinning.
• Progressively finer hairs in affected areas.
• Reduced scalp density.
• Greater scalp visibility.
• Recession around the temples or frontal hairline.
• Thinning at the crown or vertex.
• A widening central part.
• Reduced ponytail thickness.

The exact pattern differs between men and women.

Male Pattern Hair Loss and DHT

In men, androgenetic alopecia is commonly called male pattern hair loss or male pattern baldness.

It often begins with:

• Temple recession.
• A changing frontal hairline.
• Crown or vertex thinning.

These areas may gradually expand over time.

In more advanced cases, the frontal and crown regions can eventually connect, leaving denser hair mainly around the sides and back.

The Hamilton-Norwood scale is commonly used to describe the visible stages of male pattern hair loss.

Female Pattern Hair Loss and DHT

Women can also develop androgenetic alopecia. In women, it is commonly called female pattern hair loss.

However, the hormonal biology in women is more complex than simply having “too much DHT.”

Many women with female pattern hair loss have circulating androgen levels within normal laboratory ranges.

Common signs include:

• A widening central part.
• Diffuse thinning over the top of the scalp.
• Reduced ponytail thickness.
• More visible scalp under bright light.
• Progressively finer hairs around the part.

The frontal hairline is often relatively preserved.

Hormonal testing may become particularly relevant when thinning occurs alongside irregular menstrual cycles, significant acne, excess facial or body hair or other signs of androgen excess.

DHT Hair Loss vs Other Types of Hair Loss

DHT-focused treatment only makes sense when androgenetic alopecia is actually present.

Learn more about the difference between hair loss and hair breakage.

Can DHT Hair Loss Occur With Telogen Effluvium?

Yes.

Someone with androgenetic alopecia can also develop telogen effluvium.

For example, illness, childbirth, major weight loss, nutritional deficiency, medication changes or significant physiological stress may trigger additional diffuse shedding.

When this happens, genetic thinning can appear to worsen suddenly.

A sudden increase in shedding should therefore not automatically be interpreted as rapid DHT-related miniaturisation.

How DHT and Genetic Pattern Hair Loss Are Diagnosed

Androgenetic alopecia is usually diagnosed from a combination of the visible pattern, medical history, scalp examination and, when useful, trichoscopy.

Blood testing can help identify overlapping conditions, but there is no single blood test that confirms DHT-related pattern hair loss.

Medical and Family History

An assessment may include questions about:

• When thinning began.
• How quickly it has progressed.
• Which scalp areas are affected.
• Family history of pattern hair loss.
• Sudden changes in shedding.
• Illness or surgery.
• Pregnancy or childbirth.
• Major weight changes.
• Diet.
• Medications and supplements.
• Thyroid symptoms.
• Menstrual or androgen-related symptoms.

Scalp Examination

The examination should assess the:

• Frontal hairline.
• Temples.
• Crown.
• Central part.
• Hair density.
• Hair-shaft calibre.
• Scalp condition.
• Potential donor areas when transplantation is being considered.

The examiner should also look for signs that point away from uncomplicated androgenetic alopecia, such as inflammation, scarring, pustules or smooth bald patches.

Trichoscopy

Trichoscopy uses magnification to examine the scalp and hair shafts.

Findings that may support androgenetic alopecia include:

• Variation in hair-shaft diameter.
• Increased numbers of fine or miniaturised hairs.
• Reduced density in pattern-sensitive regions.
• Changes in follicular-unit composition.
• Differences between affected and relatively resistant scalp areas.

Trichoscopy can also reveal features that suggest inflammatory or scarring disease and require a different diagnostic approach.

Do You Need a DHT Blood Test?

Usually not.

A circulating DHT level does not tell you how sensitive an individual scalp follicle is to androgen signalling.

Therefore, androgenetic alopecia is not diagnosed simply by measuring DHT in the blood.

Hormonal testing may be appropriate when symptoms suggest an endocrine disorder or androgen excess, particularly in women.

When Are Other Blood Tests Useful?

Selected laboratory tests may be appropriate when the history suggests another contributor to shedding.

Depending on the individual, a clinician may consider:

• Complete blood count.
• Ferritin and iron studies.
• Thyroid function.
• Selected nutritional testing when deficiency is plausible.
• Androgen-related testing when clinically indicated.
• Assessment for PCOS when relevant symptoms are present.

There is no universal laboratory panel required for every person with pattern hair loss.

Treatment Options for DHT and Genetic Pattern Hair Loss

Androgenetic alopecia is usually a long-term condition.

Treatment aims to:

• Slow further follicular miniaturisation.
• Preserve existing hair.
• Support the active growth phase.
• Improve visible density where possible.
• Address additional causes of shedding when present.

The most appropriate treatment depends on the person’s sex, age, diagnosis, severity, medical history, reproductive considerations, treatment goals and tolerance for potential side effects.

1. Topical Minoxidil

Topical minoxidil is an established treatment for androgenetic alopecia.

It is important to understand that minoxidil does not block DHT.

Instead, it supports follicular activity through a different mechanism and can help reduce hair loss and improve growth in some patients.

Possible effects include:

• Temporary increased shedding during the early treatment period.
• Scalp dryness.
• Itching or irritation.
• Unwanted facial hair if medication repeatedly spreads beyond the scalp.

Hair responds slowly. Several months of consistent treatment are generally required before the response can be judged.

Benefits usually require continued treatment.

Women who are pregnant, planning pregnancy or breastfeeding should avoid minoxidil unless specifically advised otherwise by their healthcare professional.

2. Finasteride

Finasteride inhibits 5-alpha-reductase and reduces DHT production.

Oral finasteride is an established prescription treatment for male pattern hair loss in appropriate adult men.

It can slow progression and may improve hair growth in some patients.

Potential adverse effects and considerations should be discussed with a prescriber. These may include:

• Sexual adverse effects.
• Breast tenderness or enlargement.
• Mood-related symptoms.
• Fertility or reproductive concerns.
• Medication interactions and medical history.
• Effects on prostate-specific antigen interpretation where relevant.

Finasteride is not appropriate during pregnancy. Women who are or may be pregnant should not handle crushed or broken finasteride tablets because of potential risk to a male fetus.

Do not start, stop or alter prescription finasteride without appropriate medical guidance.

3. Topical Finasteride

Topical finasteride has been studied as a way to deliver finasteride to the scalp while potentially reducing systemic exposure compared with oral treatment.

However, systemic absorption is still possible.

Formulations, concentrations, availability and regulatory status vary between countries.

Topical finasteride should therefore not be treated as a completely risk-free or purely local alternative to oral therapy.

4. Dutasteride

Dutasteride inhibits both type I and type II 5-alpha-reductase and generally suppresses serum DHT more strongly than finasteride.

Research suggests that it can be effective for androgenetic alopecia in selected patients.

However, its approval for hair loss varies by country, and use for androgenetic alopecia is off-label in many jurisdictions.

Dutasteride has a long half-life and requires careful medical consideration.

Pregnancy and reproductive precautions are particularly important.

5. Low-Dose Oral Minoxidil

Low-dose oral minoxidil is increasingly prescribed off-label for selected patients with pattern hair loss.

Unlike finasteride and dutasteride, it does not lower DHT.

Possible adverse effects can include:

• Unwanted facial or body hair.
• Fluid retention.
• Light-headedness.
• Changes in blood pressure.
• Changes in heart rate.

Because oral minoxidil acts systemically, it requires medical assessment and appropriate monitoring.

6. Anti-Androgen Treatment for Women

Some women with female pattern hair loss may be prescribed anti-androgen treatment.

Spironolactone is one commonly used off-label option.

It may be considered particularly when hair loss occurs alongside clinical evidence of androgen excess, although treatment decisions are individualized.

Possible adverse effects include:

• Menstrual changes.
• Breast tenderness.
• Dizziness.
• Lower blood pressure.
• Changes in potassium levels.

Spironolactone is not appropriate during pregnancy and requires clinician supervision.

Finasteride or dutasteride may also be considered off-label in carefully selected women under specialist supervision, with strict reproductive precautions when pregnancy is possible.

7. Low-Level Light Therapy

Low-level light therapy, also called LLLT or photobiomodulation, uses red or near-infrared light.

Some devices have evidence supporting improved hair density in selected patients with androgenetic alopecia.

Results vary according to the device, treatment schedule and adherence.

LLLT does not replace accurate diagnosis and usually requires regular long-term use.

8. Platelet-Rich Plasma

Platelet-rich plasma (PRP) uses a concentrate prepared from the patient’s own blood and injected into the scalp.

Research suggests PRP may improve hair density or calibre in some patients with androgenetic alopecia.

However, preparation methods and treatment protocols vary considerably.

PRP is therefore better considered an adjunctive treatment than a guaranteed replacement for established medical therapy.

9. Microneedling

Microneedling has been studied as an adjunct to other treatments, particularly topical minoxidil.

Some studies suggest combination treatment may improve outcomes in selected patients.

However, inappropriate technique can cause:

• Irritation.
• Bleeding.
• Infection.
• Inflammation.
• Potential scarring.

Microneedling should not be performed over infected, painful, significantly inflamed or potentially scarring scalp disease.

10. Hair Transplantation

Hair transplantation can provide cosmetic improvement for appropriately selected patients with androgenetic alopecia.

Common approaches include follicular unit extraction (FUE) and follicular unit transplantation (FUT).

Transplanted follicles are generally selected from relatively androgen-resistant donor areas.

However, surrounding non-transplanted hair can continue to miniaturise.

For this reason, a long-term plan for native hair is often important even after transplantation.

Read our FUT vs FUE hair-transplant guide.

Which Treatments Actually Target DHT?

Not every treatment used for androgenetic alopecia is a DHT blocker.

This distinction matters because a treatment does not have to lower DHT to be useful for androgenetic alopecia.

What About Natural DHT Blockers?

Ingredients such as saw palmetto and pumpkin seed oil are frequently marketed as natural DHT blockers.

Some preliminary human research exists. However, the evidence is substantially less established than for prescription 5-alpha-reductase inhibitors.

Natural products should therefore not be presented as equivalent substitutes for finasteride or dutasteride.

They can also cause side effects or interact with medicines.

Read our evidence-focused guide to DHT-blocking ingredients for hair loss.

Can Nutritional Deficiencies Make Genetic Hair Loss Look Worse?

Yes, but nutritional deficiency does not create the inherited DHT sensitivity responsible for androgenetic alopecia.

Iron deficiency, inadequate protein or calorie intake and certain clinically significant nutrient deficiencies can contribute to additional diffuse shedding.

When this occurs alongside androgenetic alopecia, overall density can decline more noticeably.

Correcting a confirmed deficiency can address that additional contributor. It does not remove the underlying genetic susceptibility.

Learn more about nutritional drivers of hair loss and ferritin deficiency and hair loss.

Does Scalp Inflammation Cause DHT Hair Loss?

Androgenetic alopecia is not primarily an inflammatory scarring disorder.

However, scalp conditions such as seborrhoeic dermatitis, psoriasis, folliculitis or contact dermatitis can coexist with pattern hair loss.

Treating these conditions can improve scalp comfort and may make topical treatment easier to tolerate.

Persistent pain, burning, pustules, significant redness or loss of follicular openings requires evaluation for another scalp disorder rather than simply adding another DHT-focused product.

Can Stress Make Genetic Hair Loss Worse?

Stress does not create inherited androgen sensitivity.

However, major physiological or psychological stress can contribute to telogen effluvium.

This additional shedding can expose underlying pattern thinning and make hair loss appear to worsen rapidly.

Read more about the relationship between sleep and hair health.

Hair Care With Genetic Pattern Hair Loss

Hair-care practices cannot switch off genetic DHT sensitivity.

However, reducing breakage and traction helps preserve the appearance of existing hair.

• Avoid repeatedly wearing very tight hairstyles.
• Reduce excessive heat when the hair is fragile.
• Avoid overlapping bleach or aggressive chemical processing.
• Use conditioner to reduce friction.
• Detangle gently.
• Avoid harsh scalp scrubs.
• Do not apply undiluted essential oils directly to the scalp.

How Long Does DHT Hair-Loss Treatment Take?

Hair grows slowly, so treatment response should be measured over months rather than days.

Exact timelines differ by treatment and individual response.

How to Track Whether Treatment Is Working

Hair changes are gradual, so memory alone is unreliable.

1. Take baseline photographs. Include the frontal hairline, temples, central part and crown.
2. Use the same lighting. Different lighting can dramatically change apparent scalp visibility.
3. Use the same hairstyle and part.
4. Keep the camera angle and distance consistent.
5. Record treatment start dates.
6. Track side effects as well as benefits.
7. Compare over months. Avoid judging treatment from daily mirror checks.

When DHT Treatment Is Not the Right Answer

DHT-focused treatment is not appropriate for every form of hair loss.

Different management may be required for:

• Telogen effluvium.
• Alopecia areata.
• Scarring alopecia.
• Traction alopecia.
• Fungal or bacterial scalp infection.
• Inflammatory scalp disorders.
• Clinically significant nutritional deficiency.
• Thyroid-related shedding.
• Medication-related hair loss.
• Hair-shaft breakage.

If the pattern is unclear or treatment is not helping, the answer is not necessarily to add another DHT blocker.

When to See a Trichologist

A trichologist can help when you notice gradual thinning but are unsure whether the problem is pattern hair loss, shedding, breakage or a scalp condition.

A trichology assessment may include:

• Pattern assessment.
• Scalp examination.
• Hair-density documentation.
• Trichoscopic assessment where available.
• Review of hair-care practices.
• Long-term photographic monitoring.
• Identification of signs requiring medical referral.

When to See a Dermatologist or Medical Prescriber

Medical assessment is particularly important for:

• Prescription finasteride or dutasteride.
• Prescription spironolactone.
• Oral minoxidil.
• Sudden or rapidly progressing hair loss.
• Smooth bald patches.
• Scalp pain or burning.
• Pustules or significant inflammation.
• Possible scarring.
• Eyebrow or eyelash loss.
• Complex hormonal symptoms.
• Medication adverse effects.

Related DHT and Pattern Hair-Loss Guides

Frequently Asked Questions About DHT and Genetic Hair Loss

What is DHT?

DHT, or dihydrotestosterone, is an androgen produced from testosterone by the enzyme 5-alpha-reductase. It can contribute to follicular miniaturisation in genetically susceptible scalp follicles.

Does high DHT always cause hair loss?

No. Follicular sensitivity is critical. People can develop androgenetic alopecia even when circulating androgen levels are within normal ranges.

Can you have DHT hair loss with normal testosterone?

Yes. A normal testosterone result does not rule out androgenetic alopecia because local follicular sensitivity to androgen signalling is important.

Can a DHT blood test diagnose pattern hair loss?

No. There is no single blood DHT level that confirms androgenetic alopecia. Diagnosis relies primarily on the pattern, history, scalp examination and, when useful, trichoscopy.

Is genetic hair loss inherited only from the mother’s side?

No. Androgenetic alopecia has a complex inheritance pattern, and genetic factors can come from both sides of the family.

What does follicular miniaturisation mean?

Miniaturisation means susceptible follicles gradually produce finer, shorter and less visible hairs over repeated growth cycles.

What are the first signs of DHT-related hair loss in men?

Common early signs include temple recession, changes in the frontal hairline and thinning at the crown.

What are the first signs in women?

Women commonly notice a widening central part, reduced density over the top of the scalp and a smaller-feeling ponytail.

Can women have DHT-related hair loss?

Yes. Female pattern hair loss is a form of androgenetic alopecia. However, the hormonal biology in women is complex, and many affected women have normal circulating androgen levels.

Does DHT cause telogen effluvium?

Telogen effluvium has different triggers and is not simply caused by DHT. However, telogen effluvium and androgenetic alopecia can occur at the same time.

Can DHT hair loss be reversed?

Treatment can often slow or stabilize progression, and some miniaturised follicles may produce thicker hairs. Complete restoration of previous density cannot be guaranteed, particularly after long-standing advanced miniaturisation.

Is minoxidil a DHT blocker?

No. Minoxidil supports hair growth through a different mechanism and does not directly lower DHT.

Does finasteride block DHT?

Finasteride inhibits 5-alpha-reductase, reducing conversion of testosterone to DHT. It is an established prescription treatment for appropriate adult men with male pattern hair loss.

Is dutasteride stronger than finasteride?

Dutasteride inhibits both type I and type II 5-alpha-reductase and generally suppresses circulating DHT more strongly. However, regulatory approval, suitability and risk considerations differ.

Can women use finasteride or dutasteride?

These medicines may be used off-label in carefully selected women under specialist medical supervision. Pregnancy and reproductive safety require particular attention.

Does topical finasteride have systemic effects?

Systemic exposure may be lower than with oral finasteride, depending on the formulation and dose, but absorption can still occur. It should not be assumed to be completely free of systemic risk.

Are natural DHT blockers effective?

Some ingredients, including saw palmetto and pumpkin seed oil, have limited human research. The evidence is less established and less predictable than for prescription 5-alpha-reductase inhibitors.

How long does DHT treatment take to work?

Most treatments require several months. A meaningful assessment commonly requires approximately six to twelve months, depending on the treatment and individual response.

Will hair loss return if treatment stops?

Androgenetic alopecia remains biologically active. Benefits from effective medical treatments generally diminish after treatment is discontinued.

Can supplements stop genetic pattern hair loss?

Supplements do not remove inherited follicular sensitivity to androgen signalling. They may help when a genuine nutritional deficiency or inadequate intake is contributing to additional shedding.

When should I see a dermatologist?

Medical assessment is particularly important for prescription treatment, sudden or patchy loss, scalp pain, significant inflammation, possible scarring, eyebrow loss or rapidly progressive thinning.

References and Further Reading

1. 
   American Academy of Dermatology: Male Pattern Hair Loss and Treatment.
   
2. 
   American Academy of Dermatology: Female Pattern Hair Loss.
   
3. 
   StatPearls: Androgenetic Alopecia.
   
4. 
   Androgenetic Alopecia: Therapy Update.
   
5. 
   Systematic Review of Treatments for Androgenetic Alopecia.
   
6. 
   Low-Dose Oral Minoxidil for Androgenetic Alopecia.
   
7. 
   Efficacy and Safety of Topical Finasteride.
   
8. 
   Finasteride, Dutasteride and Minoxidil for Female Pattern Hair Loss.
   
9. 
   Platelet-Rich Plasma in Androgenetic Alopecia.
   
10. 
    Evidence-Based Guideline for Androgenetic Alopecia Treatment.
    

Conclusion: DHT Matters, but Follicle Sensitivity Matters Too

DHT and inherited follicular sensitivity are central to androgenetic alopecia.

In susceptible follicles, androgen signalling contributes to progressive miniaturisation. Over repeated growth cycles, affected hairs become finer, shorter and less visible.

However, DHT should not become a catch-all explanation for every type of hair loss.

Pattern recognition, scalp examination and appropriate assessment matter because telogen effluvium, nutritional deficiency, thyroid disease, medication effects, PCOS and scalp disorders can occur alongside genetic thinning.

Treatment can include topical minoxidil, finasteride for suitable men, dutasteride in selected settings, clinician-directed anti-androgen treatment for selected women, low-dose oral minoxidil, LLLT, PRP, microneedling and hair transplantation.

The correct treatment depends on the diagnosis, individual medical history and risk profile.

Most importantly, treatment works best before follicular miniaturisation becomes advanced.

Next step: read the complete androgenetic alopecia guide, learn more about DHT-blocking ingredients, or find a trichologist near you.

Medical disclaimer: This article is for general informational and educational purposes only and does not replace medical advice, diagnosis or treatment. Prescription hair-loss medicines can cause adverse effects and may not be appropriate during pregnancy, while trying to conceive, during breastfeeding or with certain medical conditions. Do not start, stop or change prescription treatment without appropriate medical guidance. Seek prompt professional assessment for sudden, patchy, painful, inflamed, infected, scar-like or rapidly progressing hair loss.